Follow
Scott Franzblau
Scott Franzblau
Director, Institute for Tuberculosis Research, University of Illinois at Chicago
Verified email at uic.edu - Homepage
Title
Cited by
Cited by
Year
Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
L Collins, SG Franzblau
Antimicrobial agents and chemotherapy 41 (5), 1004-1009, 1997
20631997
Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay
SG Franzblau, RS Witzig, JC McLaughlin, P Torres, G Madico, ...
Journal of clinical microbiology 36 (2), 362-366, 1998
12181998
Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: Anti–Mycobacterium tuberculosis activity and cytotoxicity
FR Pavan, PIS Maia, SRA Leite, VM Deflon, AA Batista, DN Sato, ...
European journal of medicinal chemistry 45 (5), 1898-1905, 2010
3792010
Structure−Activity Relationships for a Series of Quinoline-Based Compounds Active against Replicating and Nonreplicating Mycobacterium tuberculosis
A Lilienkampf, J Mao, B Wan, Y Wang, SG Franzblau, AP Kozikowski
Journal of medicinal chemistry 52 (7), 2109-2118, 2009
3722009
Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosis
SH Cho, S Warit, B Wan, CH Hwang, GF Pauli, SG Franzblau
Antimicrobial agents and chemotherapy 51 (4), 1380-1385, 2007
3662007
Antimycobacterial plant terpenoids
CL Cantrell, SG Franzblau, NH Fischer
Planta medica 67 (08), 685-694, 2001
3622001
Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter
C Changsen, SG Franzblau, P Palittapongarnpim
Antimicrobial Agents and Chemotherapy 47 (12), 3682-3687, 2003
2862003
Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis
SG Franzblau, MA DeGroote, SH Cho, K Andries, E Nuermberger, ...
Tuberculosis 92 (6), 453-488, 2012
2542012
In Vitro and In Vivo Activities of Macrolide Derivatives against Mycobacterium tuberculosis
K Falzari, Z Zhu, D Pan, H Liu, P Hongmanee, SG Franzblau
Antimicrobial agents and chemotherapy 49 (4), 1447-1454, 2005
2542005
Identification of a small molecule with activity against drug-resistant and persistent tuberculosis
F Wang, D Sambandan, R Halder, J Wang, SM Batt, B Weinrick, I Ahmad, ...
Proceedings of the National Academy of Sciences 110 (27), E2510-E2517, 2013
2492013
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents
B Zhou, Y He, X Zhang, J Xu, Y Luo, Y Wang, SG Franzblau, Z Yang, ...
Proceedings of the National Academy of Sciences 107 (10), 4573-4578, 2010
2422010
L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.
LB Adams, SG Franzblau, Z Vavrin, JB Hibbs Jr, JL Krahenbuhl
Journal of immunology (Baltimore, Md.: 1950) 147 (5), 1642-1646, 1991
2371991
Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn. (Rubiaceae)
JP Saludes, MJ Garson, SG Franzblau, AM Aguinaldo
Phytotherapy Research: An International Journal Devoted to Pharmacological …, 2002
2362002
Synthesis, antimalarial and antitubercular activity of acetylenic chalcones
RH Hans, EM Guantai, C Lategan, PJ Smith, B Wan, SG Franzblau, J Gut, ...
Bioorganic & medicinal chemistry letters 20 (3), 942-944, 2010
2292010
Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis
W Li, A Upadhyay, FL Fontes, EJ North, Y Wang, DC Crans, ...
Antimicrobial agents and chemotherapy 58 (11), 6413-6423, 2014
2192014
New perspectives on natural products in TB drug research
GF Pauli, RJ Case, T Inui, Y Wang, S Cho, NH Fischer, SG Franzblau
Life sciences 78 (5), 485-494, 2005
2132005
Drug Targeting Mycobacterium tuberculosis Cell Wall Synthesis: Genetics of dTDP-Rhamnose Synthetic Enzymes and Development of a Microtiter Plate-Based …
Y Ma, RJ Stern, MS Scherman, VD Vissa, W Yan, VC Jones, F Zhang, ...
Antimicrobial agents and chemotherapy 45 (5), 1407-1416, 2001
2062001
Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity
GC Moraski, LD Markley, PA Hipskind, H Boshoff, S Cho, SG Franzblau, ...
ACS medicinal chemistry letters 2 (6), 466-470, 2011
1962011
Antimycobacterial activity of (E)-phytol and derivatives: a preliminary structure-activity study
MS Rajab, CL Cantrell, SG Franzblau, NH Fischer
Planta medica 64 (01), 2-4, 1998
1911998
The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo
W Gao, JY Kim, JR Anderson, T Akopian, S Hong, YY Jin, O Kandror, ...
Antimicrobial agents and chemotherapy 59 (2), 880-889, 2015
1852015
The system can't perform the operation now. Try again later.
Articles 1–20